tiprankstipranks
Advertisement
Advertisement

RHHVF Stock Latest News

FDA blocked publication of studies showing Covid vaccine safe, NYT says
The FlyFDA blocked publication of studies showing Covid vaccine safe, NYT says
18h ago
AZN
BMY
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
PremiumThe Fly
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
22h ago
AZN
BMY
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
PremiumThe Fly
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
2d ago
CHRO
LCTX
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
PremiumThe Fly
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
7d ago
CHRO
Analyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
PremiumRatings
Analyst Reiterates Buy on Roche, Maintains CHF 395 Price Target on Underappreciated Long-Term Pipeline Upside
9d ago
CHRO
Genentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
PremiumThe FlyGenentech partners with comedian Damon Wayans for ‘All Eyes on DME’ campaign
12d ago
CHRO
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
Premium
The Fly
Roche upgraded to Equal Weight from Underweight at Morgan Stanley
12d ago
CHRO
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
Premium
The Fly
Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
13d ago
CHRO
Roche expects increase in group sales in mid single digit range for FY26
PremiumThe Fly
Roche expects increase in group sales in mid single digit range for FY26
13d ago
CHRO
Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
PremiumThe Fly
Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
14d ago
CHRO
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
PremiumThe Fly
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
15d ago
CHRO
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
PremiumThe Fly
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
15d ago
CHRO
Roche’s Genentech reports FDA approval of sBLA for Gazyva
PremiumThe FlyRoche’s Genentech reports FDA approval of sBLA for Gazyva
15d ago
CHRO
Trump names Erica Schwartz CDC Director
Premium
The Fly
Trump names Erica Schwartz CDC Director
20d ago
AZN
BMY
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
Premium
The Fly
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright
20d ago
CHRO
SRPT
Trump Trade: White House launches space nuclear initiative
PremiumThe Fly
Trump Trade: White House launches space nuclear initiative
20d ago
F
GM
Drugmakers raised prices on hundreds of drugs, NBC News reports
PremiumThe Fly
Drugmakers raised prices on hundreds of drugs, NBC News reports
20d ago
AZN
BMY
C4 Therapeutics expands long-term partnership with Roche
PremiumThe Fly
C4 Therapeutics expands long-term partnership with Roche
27d ago
CCCC
CHRO
Roche price target lowered to $46 from $48 at Morgan Stanley
PremiumThe Fly
Roche price target lowered to $46 from $48 at Morgan Stanley
29d ago
CHRO
Compugen initiated with a Buy at Lake Street
PremiumThe FlyCompugen initiated with a Buy at Lake Street
29d ago
AZN
MRK
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
Premium
The Fly
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
30d ago
ABBV
CHRO
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
Premium
The Fly
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
30d ago
AA
CI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >